Track the Panacea Biotec Limited stock price and the full insider trade history of the company, a listed equity based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Panacea Biotec Limited has recorded 43 public disclosures. Market capitalisation: €25.8bn. The latest transaction was filed on 1 October 2025 (Purchase). Among the most active insiders: Sandeep Jain. The full history is accessible without an account.
43
Insider Decl.
n/a
Thresholds
€27,091
6 ops.
Buy Volume
€2m
37 ops.
Sell Volume
18Σ signal
Buys €27,091€2m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 17,960 of 28,855 companies
44.4
score / 100
Value
32
Quality
57
FCF yld-1.4%
Earn yld-0.2%
EV/EBITDA·
ROE·
Gross mgn56%
Net mgn-0.8%
Debt/EBITDA0.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
123,865 shares@ ₹266.799216.2% of flowEquity SharesSEBI:dcca48c60e9141c2f5112d44cbf2119ebe6b04f7
25 of 43 declarations
About Panacea Biotec Limited
Panacea Biotec Limited is a company focused on the healthcare and pharmaceutical sector, providing innovative biopharmaceutical solutions. It is listed on the XBOM.